Chimerix reported $-97415000 in Pre-Tax Profit for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Ardelyx ARDX:US $ -33.15M 4.28M
Chimerix CMRX:US $ -97.42M 85.74M
Curis CRIS:US $ -10.84M 0.91M
Dynavax Technologies DVAX:US $ 0.89M 16.36M
Epizyme EPZM:US $ -70.27M 4.16M
Life Technologies LIFE:US $ -7.16M 2.22M
Mirati Therapeutics MRTX:US $ -135.68M 34.59M
Novavax NVAX:US $ -219.7M 42.14M
Xoma XOMA:US $ -7.37M 30.06M